Are Patients With Triple-Positive Antiphospholipid Syndrome at Higher Risk for Severe COVID-19?
Researchers assessed the severity of COVID-19 and thrombotic complications after COVID-19 vaccination in patients with high-risk antiphospholipid syndrome.